Telehealth Follow-Up for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand why some individuals with a new diabetes diagnosis from the emergency room do not follow up with a regular doctor. It will test whether telehealth visits (online doctor appointments) can better connect these patients to ongoing medical care. Participants will either have telehealth visits (Telehealth Bridge Visits) or receive standard care. Individuals recently diagnosed with diabetes in an emergency room, residing in New York City or Long Island, and speaking English or Spanish might be suitable candidates. As an unphased trial, this study offers a unique opportunity to enhance understanding and improve diabetes care for newly diagnosed patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that telehealth bridge visits are safe for diabetes follow-up?
Research has shown that telehealth visits are generally safe and effective for diabetes care. A review of several studies found that online consultations manage diabetes, including blood sugar control, as effectively as in-person visits. Another study found that telehealth services improved overall health for people with diabetes.
In a survey, 62% of participants reported that telehealth was more effective than in-person doctor visits, and 82% preferred using telehealth for their diabetes care. These findings suggest telehealth is a safe and effective choice for people with diabetes.12345Why are researchers excited about this trial?
Researchers are excited about telehealth bridge visits for diabetes management because they offer a unique way to connect patients with newly diagnosed diabetes to primary care right after an emergency department visit. Unlike traditional diabetes care, which typically involves in-person follow-up appointments and can sometimes lead to delays in care, this approach uses virtual visits to ensure timely and convenient access to healthcare professionals. This can potentially improve patient outcomes by facilitating faster intervention and personalized care plans, ultimately aiming to seamlessly transition patients from emergency care to ongoing diabetes management.
What evidence suggests that telehealth bridge visits are effective for improving follow-up care in newly diagnosed diabetes patients?
This trial will compare Telehealth Bridge Visits with Standard of Care for patients with newly diagnosed diabetes. Research has shown that telehealth bridge visits effectively connect patients to follow-up care after they leave the emergency room. Studies have found that telemedicine, which provides healthcare services remotely through technology, can replace regular in-person visits and is particularly helpful for managing diabetes. This method has delivered necessary care to patients in remote or underserved areas. Feedback from patients and healthcare providers suggests that telehealth improves access to care and helps manage diabetes effectively. Overall, telehealth bridge visits offer a promising way to ensure patients receive the follow-up care they need.678910
Who Is on the Research Team?
David C. Lee
Principal Investigator
NYU Langone Health
Are You a Good Fit for This Trial?
This trial is for emergency department patients in New York City or Long Island who speak English or Spanish, can consent to participate, and have an initial HbA1c test result of ≥ 6.5%, indicating new diabetes. It's not for those with a history of diabetes or conditions affecting the HbA1c test.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Retrospective Chart Review
Retrospective chart review of emergency department patients screened for diabetes
Qualitative Interviews
Prospective qualitative interviews among ED patients with newly diagnosed diabetes who fail to follow-up for outpatient care
Randomized Controlled Trial
Testing the efficacy of telehealth bridge visits to connect ED patients with newly diagnosed diabetes to outpatient primary care
Follow-up
Participants are monitored for completion of at least one in-person follow-up outpatient visit
What Are the Treatments Tested in This Trial?
Interventions
- Standard of Care
- Telehealth Bridge Visits
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator